Markets

Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal

1 source ·1 article ·2h ago

Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.

Covered by 1 outlet

All coverage · 1 article

Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.